M N Levine, J Hirsh. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAnimalsAnticoagulants/adverse effectsAnticoagulants/therapeutic useAspirin/pharmacologyAtrial Fibrillation/drug therapyCerebrovascular Disorders/complicationsClinical Trials as TopicCoronary Disease/complicationsDose-Response Relationship, DrugHeart Valve ProsthesisHemorrhage/chemically inducedHeparin/therapeutic useHip/surgeryHumansInjections, IntravenousInjections, SubcutaneousPartial Thromboplastin TimeProspective StudiesProtamines/therapeutic useRabbitsRetrospective StudiesRiskThromboembolism/complicationsThromboembolism/drug therapyThromboembolism/prevention & control
Substances: See more » AnticoagulantsProtaminesHeparinAspirin
Year: 1986 PMID: 3515558 DOI: 10.1055/s-2007-1003533
Source DB: PubMed Journal: Semin Thromb Hemost ISSN: 0094-6176 Impact factor: 4.180